Measurement of quantifiable parameters by time-density curves in the elastase-induced aneurysm model: first results in the comparison of a flow diverter and a conventional aneurysm stent.
BACKGROUND
Quantifiable parameters to evaluate the effectiveness of flow diverters (FDs) are desirable. We measured time-density curves (TDCs) and calculated quantifiable parameters in the rabbit elastase-induced aneurysm model after stent (Neuroform [NF]) and FD (Pipeline embolisation device [PED]) treatment.


METHODS
Sixteen rabbit elastase-induced aneurysms were treated with FD (n = 9) or NF (n = 5). Angiography was performed before and after treatment and TDCs were created. The time to peak (TTP), the full width at half maximum (FWHM) and the average slope of the curve which represent the inflow (IF) and outflow (OF) were calculated.


RESULTS
Mean values before treatment were TTP = 0.8 s, FWHM = 1.2 s, IF = 153.5 and OF = -54.9. After PED treatment, the TTP of 1.8 s and FWHM of 47.8 s were extended. The IF was 31.2 and the OF was -11.5 and therefore delayed. The values after NF treatment (TTP = 1.1 s, FWHM = 1.8 s, IF = 152.9, OF = -33.2) changed only slightly.


CONCLUSIONS
It was feasible to create TDCs in the rabbit aneurysm model. Parameters describing the haemodynamic effect of PED and NF were calculated and were different according to the type of device used. These parameters could possibly serve as predictive markers for aneurysm occlusion.
Department of Neuroradiology, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany. tobias.struffert@uk-erlangen.de
Tobias
T
Struffert
Sabine
S
Ott
Markus
M
Kowarschik
Frederik
F
Bender
Edyta
E
Adamek
Tobias
T
Engelhorn
Philipp
P
Gölitz
Stefan
S
Lang
Charles M
CM
Strother
Arnd
A
Doerfler
D000783:Aneurysm / Q000000981:diagnostic imaging* / Q000628:therapy*; D015901:Angiography, Digital Subtraction; D000818:Animals; D001783:Blood Flow Velocity; D001807:Blood Vessel Prosthesis; D004195:Disease Models, Animal; D002532:Intracranial Aneurysm / Q000000981:diagnostic imaging / Q000628:therapy*; D010196:Pancreatic Elastase / Q000009:adverse effects / Q000494:pharmacology; D011817:Rabbits; D011897:Random Allocation; D012680:Sensitivity and Specificity; D015607:Stents; D013348:Subclavian Artery; D013997:Time Factors; D014654:Vascular Patency / Q000502:physiology
D010196:Pancreatic Elastase